These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19424212)

  • 21. Lost opportunities.
    Phan P; Wong D
    Nature; 2017 Dec; 552(7683):S18. PubMed ID: 29220004
    [No Abstract]   [Full Text] [Related]  

  • 22. [Industry and pharmaceutical research in Italy. How to make up for lost time].
    Mortari U
    Recenti Prog Med; 2006 Nov; 97(11):634-9. PubMed ID: 17252720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Industry in academia: ethical frameworks would clarify links.
    Yassi A; Dharamsi S; Spiegel J
    Nature; 2010 Mar; 464(7288):486. PubMed ID: 20336109
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug patent plan gets mixed reviews.
    Butler D
    Nature; 2009 Feb; 457(7233):1064. PubMed ID: 19256077
    [No Abstract]   [Full Text] [Related]  

  • 25. Report concludes industry-academia partnerships on the wane.
    Shaffer C
    Nat Biotechnol; 2010 Jan; 28(1):7-8. PubMed ID: 20062022
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacotherapy crisis in the spotlight--is open collaboration between academia and industry the answer?
    Kaski JC
    Cardiovasc Drugs Ther; 2011 Apr; 25(2):187-8. PubMed ID: 21503624
    [No Abstract]   [Full Text] [Related]  

  • 27. Academic, Foundation, and Industry Collaboration in Finding New Therapies.
    Ramsey BW; Nepom GT; Lonial S
    N Engl J Med; 2017 May; 376(18):1762-1769. PubMed ID: 28467868
    [No Abstract]   [Full Text] [Related]  

  • 28. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia].
    Iida K; Yano T; Ikemori M; Ishida T; Nishimura N
    Yakugaku Zasshi; 2021 Jun; 141(6):877-886. PubMed ID: 33642438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Academia-pharma partnerships for novel drug discovery: essential or nice to have?
    Palmer M; Chaguturu R
    Expert Opin Drug Discov; 2017 Jun; 12(6):537-540. PubMed ID: 28394189
    [No Abstract]   [Full Text] [Related]  

  • 30. [From intellectual property to commercial property].
    Cappelaere P
    Bull Cancer; 2005 Apr; 92(4):297-8. PubMed ID: 15888384
    [No Abstract]   [Full Text] [Related]  

  • 31. Dusting off outdated patterns.
    Munroe I
    Nature; 2017 Mar; 543(7646):S23-S26. PubMed ID: 28328911
    [No Abstract]   [Full Text] [Related]  

  • 32. Are academia-pharma partnerships essential for novel drug discovery in the time of the COVID-19 pandemic?
    Lexchin J
    Expert Opin Drug Discov; 2021 May; 16(5):475-479. PubMed ID: 33307875
    [No Abstract]   [Full Text] [Related]  

  • 33. Ownership of knowledge--the role of patents in pharmaceutical R&D.
    Correa CM
    Bull World Health Organ; 2004 Oct; 82(10):784-7; discussion 787-90. PubMed ID: 15643801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Universities need a new social contract.
    Samarasekera IV
    Nature; 2009 Nov; 462(7270):160-1. PubMed ID: 19907477
    [No Abstract]   [Full Text] [Related]  

  • 35. IP litigation in China could drive innovation.
    Jia H
    Nat Biotechnol; 2004 Apr; 22(4):368. PubMed ID: 15060539
    [No Abstract]   [Full Text] [Related]  

  • 36. Interactions of the public and private sectors in drug development: boundaries to protect scientific values while preserving innovation.
    Cassell GH
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S45-8; discussion S51-9. PubMed ID: 17469473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Public-private relationships in biobanking: a still underestimated key component of open innovation.
    Hofman P; Bréchot C; Zatloukal K; Dagher G; Clément B
    Virchows Arch; 2014 Jan; 464(1):3-9. PubMed ID: 24337181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Idea of Patents vs. the Idea of University.
    de Campos TC
    New Bioeth; 2015; 21(2):164-76. PubMed ID: 27124964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Balancing basic and applied research. In a time of economic changes and stagnating support from the government, universities have to restructure and reshape their mission.
    Oosterlinck A; Debackere K; Cielen G
    EMBO Rep; 2002 Jan; 3(1):2-5. PubMed ID: 11799049
    [No Abstract]   [Full Text] [Related]  

  • 40. Origins of medical innovation: the case of coronary artery stents.
    Xu S; Avorn J; Kesselheim AS
    Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):743-9. PubMed ID: 23093563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.